Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,040 | 765 | 99.1% |
| Education | $162.04 | 3 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,003 | 165 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,120 | 77 | $0 (2024) |
| GENZYME CORPORATION | $2,082 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,712 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $917.97 | 50 | $0 (2024) |
| PFIZER INC. | $820.78 | 39 | $0 (2024) |
| Amgen Inc. | $771.87 | 29 | $0 (2024) |
| kaleo, Inc. | $771.53 | 40 | $0 (2024) |
| Grifols USA, LLC | $745.68 | 32 | $0 (2024) |
| Optinose US, Inc. | $651.36 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,964 | 168 | GENZYME CORPORATION ($741.93) |
| 2023 | $4,995 | 185 | Regeneron Healthcare Solutions, Inc. ($848.32) |
| 2022 | $4,276 | 185 | GlaxoSmithKline, LLC. ($829.18) |
| 2021 | $2,515 | 131 | GlaxoSmithKline, LLC. ($416.96) |
| 2020 | $1,185 | 80 | GlaxoSmithKline, LLC. ($305.56) |
| 2019 | $86.20 | 3 | GENZYME CORPORATION ($64.06) |
| 2018 | $28.80 | 2 | GlaxoSmithKline, LLC. ($18.16) |
| 2017 | $151.04 | 14 | Teva Pharmaceuticals USA, Inc. ($134.74) |
All Payment Transactions
768 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2024 | Amgen Inc. | ACTIMMUNE (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Bone/Inflammation/Rare Disease | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Greer Laboratories, Inc. | Palforzia (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Allergy Treatment | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $118.71 | General |
| 12/04/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.47 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/15/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Immunology and Neurology | ||||||
| 11/14/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $32.21 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Immunology | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 516 | 1,579 | $223,805 | $46,969 |
| 2022 | 16 | 481 | 1,430 | $181,230 | $48,080 |
| 2021 | 17 | 469 | 4,520 | $443,376 | $111,857 |
| 2020 | 16 | 380 | 4,012 | $409,217 | $107,352 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 136 | $56,160 | $14,183 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 150 | $43,980 | $11,162 | 25.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 17 | 310 | $16,325 | $4,323 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 35 | 35 | $13,875 | $3,253 | 23.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 53 | 91 | $14,320 | $2,179 | 15.2% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 33 | 215 | $24,270 | $2,150 | 8.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $7,555 | $1,766 | 23.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 59 | 98 | $9,310 | $1,686 | 18.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 115 | $7,420 | $1,404 | 18.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 21 | 25 | $4,400 | $1,257 | 28.6% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 13 | 294 | $14,700 | $1,210 | 8.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 11 | 11 | $3,080 | $833.91 | 27.1% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 15 | 15 | $5,205 | $550.50 | 10.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $1,425 | $539.70 | 37.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 56 | $1,780 | $470.40 | 26.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 144 | $54,720 | $16,741 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 111 | $28,860 | $9,020 | 31.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 47 | 75 | $11,650 | $3,798 | 32.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 15 | 240 | $12,000 | $3,634 | 30.3% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 25 | 235 | $14,130 | $2,506 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $8,700 | $2,356 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $8,470 | $2,285 | 27.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 47 | 70 | $9,100 | $1,616 | 17.8% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 52 | 85 | $7,015 | $1,491 | 21.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 89 | $5,340 | $1,117 | 20.9% |
About Dr. Robert Corriel, M.D
Dr. Robert Corriel, M.D is a Allergy & Immunology healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588669519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Corriel, M.D has received a total of $18,202 in payments from pharmaceutical and medical device companies, with $4,964 received in 2024. These payments were reported across 768 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($18,040).
As a Medicare-enrolled provider, Corriel has provided services to 1,846 Medicare beneficiaries, totaling 11,541 services with total Medicare billing of $314,257. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Manhasset, NY
- Active Since 06/16/2005
- Last Updated 04/30/2008
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1588669519
Products in Payments
- DUPIXENT (Biological) $3,946
- TRELEGY ELLIPTA (Drug) $1,379
- NUCALA (Biological) $1,331
- TEZSPIRE (Biological) $1,130
- AUVI-Q (Drug) $771.53
- Xembify (Biological) $730.17
- Xhance (Drug) $651.36
- CUVITRU (Biological) $584.79
- OPZELURA (Drug) $552.20
- Xolair (Biological) $473.36
- AIRSUPRA (Drug) $449.16
- BREZTRI (Drug) $353.11
- AYVAKIT (Drug) $350.97
- CUTAQUIG (Biological) $335.00
- ORLADEYO (Drug) $325.31
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $288.52
- FASENRA (Biological) $280.41
- EUCRISA (Drug) $269.49
- TAKHZYRO (Biological) $218.92
- Odactra (Drug) $218.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.